Similar content being viewed by others
This article is cited by
-
SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
Cell Death & Disease (2023)
-
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors
Cancer Immunology, Immunotherapy (2023)
-
Update on Immune Checkpoint Inhibitor Enterocolitis
Current Gastroenterology Reports (2022)